Recursion Pharma is Going Public
Utah’s hottest biotech firm, Recursion Pharmaceuticals, is taking advantage of
the red hot stock market as it has announced plans for a $100 million Initial
Public Offering.
Over $1 billion
[https://www.biopharmadive.com/news/new-drug-cost-research-development-market-jama-study/573381/#:~:text=Between%202009%20and%202018%2C%20the,the%20London%20School%20of%20Economics.